Clinical Trial Update: A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Adebrelimab plus SHR-A1811/SHR-A1904 with chemotherapy or SHR-8068 for gastric and gastroesophageal junction cancers; currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-8068
• SHR-A1811
• SHR-A1904

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Gastric Cancer, Gastroesophageal-junction Cancer | Phase 2 | Status: RECRUITING